NovoCure Ltd·4

Jan 3, 4:04 PM ET

Cordova Ashley 4

4 · NovoCure Ltd · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2024-12-31
Cordova Ashley
Former Chief Executive Officer
Transactions
  • Award

    Ordinary Shares

    2024-12-31$14.75/sh+373$5,501219,552 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2024 through December 31, 2024. This transaction is also exempt under Rule 16b-3(c).
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2024.

Documents

2 files